Robert J. Ferrante, PhD

Affiliations: 
Neurology, Pathology, & Psychiatry Boston University, Boston, MA, United States 
Area:
http://www.biomedexperts.com/Profile.bme/395895/Robert_J_Ferrante
Website:
http://www.bu.edu/alzresearch/team/faculty/ferrante.html
Google:
"Robert Ferrante"
Bio:

http://www.bumc.bu.edu/busm-bns/faculty/

http://www.bu.edu/research/highlights/awards/honors-awards-2007/

Mean distance: 15.32 (cluster 24)
 
SNBCP
Cross-listing: Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tourette C, Farina F, Vazquez-Manrique RP, et al. (2014) The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicity. Plos Biology. 12: e1001895
Yano H, Baranov SV, Baranova OV, et al. (2014) Inhibition of mitochondrial protein import by mutant huntingtin. Nature Neuroscience. 17: 822-31
Zhang Y, Cook A, Kim J, et al. (2013) Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease. 55: 26-35
Taylor DM, Moser R, Régulier E, et al. (2013) MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 2313-25
Chopra V, Quinti L, Kim J, et al. (2012) The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models. Cell Reports. 2: 1492-7
Landis SC, Amara SG, Asadullah K, et al. (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 490: 187-91
Zhang Y, Benmohamed R, Zhang W, et al. (2012) Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALS. Acs Medicinal Chemistry Letters. 3: 584-587
Wright PD, Wightman N, Huang M, et al. (2012) A high-throughput screen to identify inhibitors of SOD1 transcription. Frontiers in Bioscience (Elite Edition). 4: 2801-8
Chen T, Benmohamed R, Kim J, et al. (2012) ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis. Journal of Medicinal Chemistry. 55: 515-27
Zhang W, Benmohamed R, Arvanites AC, et al. (2012) Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells. Bioorganic & Medicinal Chemistry. 20: 1029-45
See more...